thrombotic thromboembolic complications

Related by string. Thrombotic thromboembolic complications * Thrombotic : thrombotic thrombocytopenic purpura TTP . anti thrombotic Lovenox . thrombotic disorders malignant neoplasm / thrombo embolic . Thromboembolic : venous thromboembolic events . thromboembolic complications / COMPLICATIONS . Complications : diabetic complications . Face Complications Possible * *

Related by context. Frequent words. (Click for all words.) 58 thromboembolism 58 orthostatic hypotension 57 metabolic acidosis 57 hepatotoxicity 57 tumor lysis syndrome 57 thromboembolic events 57 thrombotic events 56 REMICADE ® 56 Neutropenia 56 hypomagnesemia 56 hypercalcemia 56 QTc interval 55 hyperkalemia 55 COPD exacerbations 55 discontinuations due 54 hypoglycemic events 54 lactic acidosis 54 hypocalcemia 53 myelosuppression 53 urinary retention 53 angioedema 53 intracerebral hemorrhage 53 SILENOR TM 52 discontinuations 52 vasomotor symptoms 52 neuropsychiatric symptoms 52 mycophenolate mofetil 52 cerebrovascular events 52 renal insufficiency 52 severe hypoglycemia 52 impaired renal 52 febrile neutropenia 52 infusion reactions 52 Adverse reactions 52 lymphopenia 51 QT prolongation 51 diarrhea nausea vomiting 51 amenorrhea 51 myocardial infarction stroke 51 serotonin syndrome 51 leukopenia 51 peripheral edema 51 lacosamide 51 RLS symptoms 51 diabetic neuropathic pain 51 liver dysfunction 51 morbidity mortality 50 NUEDEXTA 50 limiting toxicity 50 Secondary endpoints included 50 hypersensitivity reaction 50 radiation dermatitis 49 hyperbilirubinemia 49 Market Disruption 49 immunosuppressive agents 49 nasopharyngitis 49 vernakalant oral 49 nausea diarrhea 49 Secondary endpoints include 49 omecamtiv mecarbil 48 dose limiting toxicities 48 androgen deprivation 48 thrombocytopenia 48 Secondary endpoints 48 akathisia 48 photosensitivity 47 liver toxicity 47 laboratory abnormalities 47 GEMZAR 47 events AEs 47 treatment emergent adverse 47 cardiac toxicity 47 Anturol 47 mucositis 47 Discontinuation 47 hypersensitivity reactions 46 cSSSI 46 NEUMUNE 46 congenital malformations 46 SREs 46 indomethacin 46 events SAEs 46 stroke myocardial infarction 46 systemic absorption 46 antiepileptic drugs 46 anaphylactic reactions 46 inhaled nitric oxide 45 rhythm abnormalities 45 hypoglycaemia 45 hypoglycemia 45 spinal cord compression 45 #mg dose [003] 45 divalproex 45 immune suppression 45 thrombotic 45 risks anduncertainties 44 xxv 44 acute coronary 44 itraconazole 44 neutropenia 44 TYSABRI treated

Back to home page